Medincell and AbbVie today announced a collaboration to co-develop and commercialize up to six therapeutic products across several areas. The partnership spans multiple therapeutic spaces and indications. Under the agreement, Medincell will use its commercial-stage, long-acting injectable technology platform to formulate innovative therapies. It plans to conduct formulation activities and preclinical studies, including supportive CMC…